Comparison of pharmacokinetic profiles of doramectin and ivermectin pour-on formulations in cattle

被引:79
作者
Gayrard, V
Alvinerie, M
Toutain, PL
机构
[1] Ecole Natl Vet, Unite Associee INRA Physiopathol & Toxicol Expt, F-31076 Toulouse, France
[2] INRA, Stn Pharmacol, F-31391 Toulouse, France
关键词
doramectin; ivermectin; pour-on; pharmacokinetics; cattle;
D O I
10.1016/S0304-4017(98)00236-2
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The plasma pharmacokinetics of doramectin and invermectin after topical administration (500 mu g kg(-1)) were compared over a 50-day period in 24 young beef cattle. Observed maximum concentration (C-max) and time to maximum concentration (T-max) were determined directly from plasma concentrations for each animal. The area under the plasma concentration-time curve (AUC) and mean residence time (MRT) were calculated as indices of drug exposure and persistence. The C-max of doramectin (12.2 +/- 4.8 ng ml(-1)) and ivermectin (12.2 +/- 6.0 ng ml(-1)) and T-max of doramectin (4.3 +/- 1.6 days) and ivermectin (3.4 +/- 0.8 days) were not significantly different (p > 0.05). In contrast, the AUC of doramectin (168.0 +/- 41.7 ng day ml(-1)) was significantly greater than that of ivermectin (115.5 +/- 43.0 ng day ml(-1)). Furthermore, the range of AUC values calculated for ivermectin was wider than that obtained for doramectin, extending from 51.3 to 182.3 ng day ml(-1) for ivermectin versus 104.3-228.7 ng day ml(-1) for doramectin. The MRT was significantly greater for doramectin (12.8 +/- 1.9 days) than for ivermectin (8.4 +/- 1.5 days). It was concluded that a 500 mu g kg(-1) pour-on administration of doramectin and ivermectin led to an overall exposure as reflected by the mean AUG, that was 45% higher for doramectin compared to ivermectin and that the relative inter-individual variability was less for doramectin than for ivermectin. Possible therapeutic consequences of these differences between doramectin and ivermectin pour-on formulations are discussed. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 17 条
[1]   DETERMINATION OF MOXIDECTIN IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH AUTOMATED SOLID-PHASE EXTRACTION AND FLUORESCENCE DETECTION [J].
ALVINERIE, M ;
SUTRA, JF ;
BADRI, M ;
GALTIER, P .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 674 (01) :119-124
[2]  
BREMNER KC, 1983, VET REC, V113, P569
[3]   IVERMECTIN - A REVIEW OF EFFICACY AND SAFETY [J].
CAMPBELL, WC ;
BENZ, GW .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1984, 7 (01) :1-16
[4]   METHOD VALIDATION REVISITED - A CHEMOMETRIC APPROACH [J].
CARDONE, MJ ;
WILLAVIZE, SA ;
LACY, ME .
PHARMACEUTICAL RESEARCH, 1990, 7 (02) :154-160
[5]  
DEMONTIGNY P, 1990, J PHARM BIOMED ANAL, V8, P505
[6]   DORAMECTIN - A POTENT NOVEL ENDECTOCIDE [J].
GOUDIE, AC ;
EVANS, NA ;
GRATION, KAF ;
BISHOP, BF ;
GIBSON, SP ;
HOLDOM, KS ;
KAYE, B ;
WICKS, SR ;
LEWIS, D ;
WEATHERLEY, AJ ;
BRUCE, CI ;
HERBERT, A ;
SEYMOUR, DJ .
VETERINARY PARASITOLOGY, 1993, 49 (01) :5-15
[7]  
GUILLOT FS, 1986, AM J VET RES, V47, P525
[8]   Persistence of ivermectin in plasma and faeces following treatment of cows with ivermectin sustained-release, pour-on or injectable formulations [J].
Herd, RP ;
Sams, RA ;
Ashcraft, SM .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1996, 26 (10) :1087-1093
[9]   Avermectins and milbemycins [J].
McKellar, QA ;
Benchaoui, HA .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1996, 19 (05) :331-351
[10]  
Nies AS, 1996, GOODMAN GILMANS PHAR, P43